Clinical Trial Update: Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Vitamin E for prophylaxis of oxaliplatin-induced peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: Felipe Melo Cruz | Conditions: Peripheral Neuropathy | Phase 2 | Status: COMPLETED